
|Articles|February 1, 2011
- Applied Clinical Trials-02-01-2011
- Volume 20
- Issue 2
Applied Clinical Trials Digital Edition - February 2011
INFORMATION TECHNOLOGY : A Risk-Based Approach for Computer Systems Validation SITES : Trial Monitoring - Source Document Verification REGULATORY : FDA's Guidance on Patient-Reported Outcomes ALSO IN THIS ISSUE : FDA's Oversight Capabilities Increased, Influenza Warning Issued, Cloud Computing: A Reality?, Guidance Says Focus on the Patient
Advertisement
Articles in this issue
over 15 years ago
Applied Clinical Trials Digital Edition - February 2011, Supplementover 15 years ago
Rates Increase Abroad Due to High Demandover 15 years ago
Hispanics Remain Minority in Clinical Trialsover 15 years ago
State Cash Fuels Growth in Englandover 15 years ago
Act Coverover 15 years ago
Biosimilars in the US & EU Regulatory Pathwaysover 15 years ago
The FDA's Guidance on PROover 15 years ago
H1N1 Influenza: Not to be Sneezed atover 15 years ago
Cardiovascular Drug Trial Discontinuedover 15 years ago
New Approach to System ValidationAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The CRA of the Future: From Monitoring Activity to Strategic Site Partnership
2
Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad
3
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
4
Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV
5




